Judith Parsons
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Judith Parsons has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Angus Forbes
Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care King's College London London UK
12 shared publications - Rita Forde
School of Nursing and Midwifery University College Cork Cork Ireland
8 shared publications - Khalida Ismail
Department of Psychological Medicine, Diabetes, Psychology and Psychiatry Research Group, King’s College London, London, UK
3 shared publications Rita Forde
School of Nursing and Midwifery, University College Cork Cork Ireland
3 shared publicationsAngus Forbes
Division of Care for Long-term Conditions, Florence Nightingale Faculty of Nursing, Midwifery, and Palliative Care, London SE18WA, UK
2 shared publicationsAnna Brackenridge
Department of Diabetes and Endocrinology, Guy's and St Thomas' Hospitals NHS Trust, London, London, UK
2 shared publications
Latest Publications
- Open Access
- 18 June 2026
- Published by Wiley in Diabetic Medicine
- Vol. 43 (9) , e70389
Women living with diabetes: Overlooked and under‐recognised, the psychosocial impact
Aim: Diabetes intersects with women's reproductive and sexual health across the life course; however, the psychosocial implications of key reproductive transitions remain under‐recognised in research and clinical practice. This review synthesised evidence on the psychosocial impacts of diabetes during menstruation, pregnancy, the menopausal transition and sexual functioning, with the aim of identifying critical gaps in research and care. Methods: A narrative review was conducted, informed by a semi‐structured literature search. Findings: Women living with diabetes experience substantial psychosocial burdens that extend beyond glycaemic management across all reproductive stages. During menstruation, hormonal fluctuations contribute to glycaemic variability, increased self‐management demands and emotional distress, often without adequate clinical guidance. Pregnancy in women with type 1, type 2, and gestational diabetes is associated with heightened anxiety, diabetes distress, stigma and guilt, yet psychosocial needs remain largely unaddressed in routine care. The menopausal transition represents a further period of vulnerability, characterised by worsening glycaemic variability, increased psychological morbidity and elevated cardiovascular risk. Sexual dysfunction is highly prevalent across the lifespan in women with diabetes and is strongly associated with depression, anxiety and body image concerns. Conclusion: Overall, the evidence highlights a persistent disconnect between the psychosocial needs of women and the predominantly biomedical focus of current diabetes care models. Addressing this gap requires a person‐centred approach that integrates psychosocial and women‐specific health considerations into diabetes research, education and clinical practice. Strengthening this evidence base is essential to improving long‐term health outcomes for women living with diabetes.
- 18 June 2026
- Published by Wiley in Diabetic Medicine
- Vol. 43 (9) , e70389
Open AccessWomen living with diabetes: Overlooked and under‐recognised, the psychosocial impact
Aim: Diabetes intersects with women's reproductive and sexual health across the life course; however, the psychosocial implications of key reproductive transitions remain under‐recognised in research and clinical practice. This review synthesised evidence on the psychosocial impacts of diabetes during menstruation, pregnancy, the menopausal transition and sexual functioning, with the aim of identifying critical gaps in research and care. Methods: A narrative review was conducted, informed by a semi‐structured literature search. Findings: Women living with diabetes experience substantial psychosocial burdens that extend beyond glycaemic management across all reproductive stages. During menstruation, hormonal fluctuations contribute to glycaemic variability, increased self‐management demands and emotional distress, often without adequate clinical guidance. Pregnancy in women with type 1, type 2, and gestational diabetes is associated with heightened anxiety, diabetes distress, stigma and guilt, yet psychosocial needs remain largely unaddressed in routine care. The menopausal transition represents a further period of vulnerability, characterised by worsening glycaemic variability, increased psychological morbidity and elevated cardiovascular risk. Sexual dysfunction is highly prevalent across the lifespan in women with diabetes and is strongly associated with depression, anxiety and body image concerns. Conclusion: Overall, the evidence highlights a persistent disconnect between the psychosocial needs of women and the predominantly biomedical focus of current diabetes care models. Addressing this gap requires a person‐centred approach that integrates psychosocial and women‐specific health considerations into diabetes research, education and clinical practice. Strengthening this evidence base is essential to improving long‐term health outcomes for women living with diabetes.
- Open Access
- 9 May 2026
- Published by Wiley in Diabetic Medicine
- Vol. 43 (7) , e70352
Psychosocial care and experiences in young adults living with early‐onset type 2 diabetes: A narrative review
Aims: To review the literature on psychosocial care and experiences of young adults with early‐onset type 2 diabetes (EOT2D), to identify what is known, current gaps and to develop recommendations to help advance psychosocial care and support for the population. Methods: We searched Medline (Ovid), Google Scholar and diabetes‐specific journals for English‐language articles focused on psychosocial aspects in young adults (aged 18–45 years) with EOT2D. Two people with lived experience reviewed and commented on the review findings. Results: Growing evidence indicates that a diagnosis of EOT2D is associated with an increased risk of developing diabetes‐related psychological comorbidities. Experiences of diabetes‐related stigma, compounded by age‐related negative preconceptions, contribute to heightening the psychosocial impact of EOT2D. Some population sub‐groups appear to be more likely to experience adverse psychological effects. However, the evidence base is limited by a dearth of diverse research specifically focused on the psychosocial experiences and needs of this population (e.g., longitudinal and qualitative studies). Adults with EOT2D also experience unmet education, care and support needs relevant to optimising their psychosocial well‐being and diabetes management. Overall, they require enhanced, tailored care and support that is age‐appropriate, person‐centred and responsive to their psychosocial needs. Digital technology and support‐based strategies may help to address current gaps and improve the psychological well‐being of this group, but these require further exploration. Conclusions: Despite the importance of psychosocial factors in young adults' diabetes management and outcomes, there remain gaps in research and practice and the need for further research, alongside changes in practice.
- 9 May 2026
- Published by Wiley in Diabetic Medicine
- Vol. 43 (7) , e70352
Open AccessPsychosocial care and experiences in young adults living with early‐onset type 2 diabetes: A narrative review
Aims: To review the literature on psychosocial care and experiences of young adults with early‐onset type 2 diabetes (EOT2D), to identify what is known, current gaps and to develop recommendations to help advance psychosocial care and support for the population. Methods: We searched Medline (Ovid), Google Scholar and diabetes‐specific journals for English‐language articles focused on psychosocial aspects in young adults (aged 18–45 years) with EOT2D. Two people with lived experience reviewed and commented on the review findings. Results: Growing evidence indicates that a diagnosis of EOT2D is associated with an increased risk of developing diabetes‐related psychological comorbidities. Experiences of diabetes‐related stigma, compounded by age‐related negative preconceptions, contribute to heightening the psychosocial impact of EOT2D. Some population sub‐groups appear to be more likely to experience adverse psychological effects. However, the evidence base is limited by a dearth of diverse research specifically focused on the psychosocial experiences and needs of this population (e.g., longitudinal and qualitative studies). Adults with EOT2D also experience unmet education, care and support needs relevant to optimising their psychosocial well‐being and diabetes management. Overall, they require enhanced, tailored care and support that is age‐appropriate, person‐centred and responsive to their psychosocial needs. Digital technology and support‐based strategies may help to address current gaps and improve the psychological well‐being of this group, but these require further exploration. Conclusions: Despite the importance of psychosocial factors in young adults' diabetes management and outcomes, there remain gaps in research and practice and the need for further research, alongside changes in practice.
- Open Access
- 11 April 2025
- Published by Wiley in Diabetic Medicine
- Vol. 42 (8) , e70043
Barriers and facilitators to attending postpartum diabetes screening among women with previous gestational diabetes in China: A qualitative analysis
Introduction: Gestational diabetes mellitus (GDM) is a common complication of pregnancy associated with a higher risk of developing type 2 diabetes (T2DM) in the future. Postpartum diabetes screening is important to identify glucose intolerance and introduce diabetes prevention support. However, screening uptake is suboptimal, including in China where the prevalence of GDM is high. There is limited evidence on the barriers and facilitators to screening uptake among Chinese women. Aims: To explore the barriers and facilitators of postpartum diabetes screening uptake among Chinese women with GDM to inform the development of an intervention to increase screening attendance. Methods: Women with current or previous GDM were recruited from social network platforms and pregnancy groups in China. Data were collected using semi‐structured interviews and analysed using Framework Analysis to identify themes related to the barriers and facilitators for screening uptake. Results: Twenty‐four women with current ( n = 4) or previous ( n = 20) GDM participated. The postpartum glucose screening attendance rate was 35% among those with previous GDM. Screening uptake was influenced by: risk awareness of T2DM and its complications, interactions with healthcare providers (HCPs), screening‐related factors (understanding and beliefs, accessibility and acceptability of the test) and motivation to maintain personal health, which was influenced by fear of T2DM, lack of symptoms, confidence in self management without support, and prioritisation of the child's needs. Conclusion: Postpartum screening uptake after GDM could be boosted through raising risk awareness, more constructive communication from HCPs, increasing the acceptability and accessibility of screening procedures, and addressing psychological factors related to attendance.
- 11 April 2025
- Published by Wiley in Diabetic Medicine
- Vol. 42 (8) , e70043
Open AccessBarriers and facilitators to attending postpartum diabetes screening among women with previous gestational diabetes in China: A qualitative analysis
Introduction: Gestational diabetes mellitus (GDM) is a common complication of pregnancy associated with a higher risk of developing type 2 diabetes (T2DM) in the future. Postpartum diabetes screening is important to identify glucose intolerance and introduce diabetes prevention support. However, screening uptake is suboptimal, including in China where the prevalence of GDM is high. There is limited evidence on the barriers and facilitators to screening uptake among Chinese women. Aims: To explore the barriers and facilitators of postpartum diabetes screening uptake among Chinese women with GDM to inform the development of an intervention to increase screening attendance. Methods: Women with current or previous GDM were recruited from social network platforms and pregnancy groups in China. Data were collected using semi‐structured interviews and analysed using Framework Analysis to identify themes related to the barriers and facilitators for screening uptake. Results: Twenty‐four women with current ( n = 4) or previous ( n = 20) GDM participated. The postpartum glucose screening attendance rate was 35% among those with previous GDM. Screening uptake was influenced by: risk awareness of T2DM and its complications, interactions with healthcare providers (HCPs), screening‐related factors (understanding and beliefs, accessibility and acceptability of the test) and motivation to maintain personal health, which was influenced by fear of T2DM, lack of symptoms, confidence in self management without support, and prioritisation of the child's needs. Conclusion: Postpartum screening uptake after GDM could be boosted through raising risk awareness, more constructive communication from HCPs, increasing the acceptability and accessibility of screening procedures, and addressing psychological factors related to attendance.
- Open Access
- 5 March 2025
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 13 (2) , e004312
Medication prescribing and pregnancy-related risk factors for women with type 2 diabetes of reproductive age within primary care: a cross-sectional investigation for the PREPARED study
Introduction: Women with type 2 diabetes are at risk of commencing pregnancy while using medications that are either not recommended for pregnancy or with known teratogenicity, which may contribute to adverse pregnancy outcomes. In this study, we aimed to characterize pregnancy-related risk factors and medication exposures among women with type 2 diabetes. Research design and methods: Individual health characteristics, sociodemographic information, and prescription data were extracted from the primary care records of women aged 18–45 years with type 2 diabetes in participating general practices in the UK. Prescribed medications were categorized according to suitability for pregnancy: recommended, not recommended, or not recommended but used if clinically indicated. Logistic regression was used to estimate associations between individual characteristics and medications not recommended for pregnancy. Results: Data on 725 women were extracted. Prescribed medications suggested the presence of numerous comorbidities, with diabetes medications (65%, n=471) and statins (20%, n=145) most frequently prescribed. 37% (n=268) of women took ≥3 medications, and a third (n=269) took medications not recommended for pregnancy. Among those not prescribed contraception (89%, n=646), no one met all clinically recommended pre-pregnancy criteria. In multivariable logistic regression analysis, polypharmacy (OR 3.49 95% CI 2.88 to 4.30) and age (OR 1.04 95% CI 1.00 to 1.09) were associated with use of medications not recommended for pregnancy. Conclusions: Women with type 2 diabetes have suboptimal contraceptive provision despite multiple exposures to medications not recommended for pregnancy. Regular assessment of contraceptive use, reproductive intentions, and medication review is urgently needed in primary care settings to minimize pregnancy-related risks.
- 5 March 2025
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 13 (2) , e004312
Open AccessMedication prescribing and pregnancy-related risk factors for women with type 2 diabetes of reproductive age within primary care: a cross-sectional investigation for the PREPARED study
Introduction: Women with type 2 diabetes are at risk of commencing pregnancy while using medications that are either not recommended for pregnancy or with known teratogenicity, which may contribute to adverse pregnancy outcomes. In this study, we aimed to characterize pregnancy-related risk factors and medication exposures among women with type 2 diabetes. Research design and methods: Individual health characteristics, sociodemographic information, and prescription data were extracted from the primary care records of women aged 18–45 years with type 2 diabetes in participating general practices in the UK. Prescribed medications were categorized according to suitability for pregnancy: recommended, not recommended, or not recommended but used if clinically indicated. Logistic regression was used to estimate associations between individual characteristics and medications not recommended for pregnancy. Results: Data on 725 women were extracted. Prescribed medications suggested the presence of numerous comorbidities, with diabetes medications (65%, n=471) and statins (20%, n=145) most frequently prescribed. 37% (n=268) of women took ≥3 medications, and a third (n=269) took medications not recommended for pregnancy. Among those not prescribed contraception (89%, n=646), no one met all clinically recommended pre-pregnancy criteria. In multivariable logistic regression analysis, polypharmacy (OR 3.49 95% CI 2.88 to 4.30) and age (OR 1.04 95% CI 1.00 to 1.09) were associated with use of medications not recommended for pregnancy. Conclusions: Women with type 2 diabetes have suboptimal contraceptive provision despite multiple exposures to medications not recommended for pregnancy. Regular assessment of contraceptive use, reproductive intentions, and medication review is urgently needed in primary care settings to minimize pregnancy-related risks.
- Open Access
- 20 September 2024
- Published by Wiley in Diabetic Medicine
- Vol. 42 (1) , e15439
Qualitative study exploring the experiences of sexual dysfunction in premenopausal women with type 1 diabetes
Aims: To explore the sexual experiences and interactions of women with type 1 diabetes to explicate an understanding of the impact of diabetes on women's sexual function. The study was conducted as part of a wider project to develop a patient‐reported outcome measure to assess sexual dysfunction (SD) in premenopausal women with type 1 diabetes.Methods: A qualitative study using face‐to‐face and virtual semi‐structured interviews was conducted with premenopausal women with type 1 diabetes who have had some difficulties related to sexual functioning. Participants were recruited from two National Health Services (NHS) sites in the UK and from social media platforms. The data were analysed to generate themes using Framework Analysis approach.Results: Eighteen women, aged 22–49, were interviewed (NHS sites n = 13; online n = 5). Five themes related to women experiences of SD were identified, these were; initiation of sexual activity, sexual confidence, sexual enjoyment, sexual engagement and sexual desire.Conclusions: SD in women with type 1 diabetes is a complex phenomenon impacting their experiences and quality of life. SD is related to multiple interacting biopsychosocial factors related to diabetes, including blood glucose levels, diabetes treatments, technologies and complications. A targeted measure of SD for women with type 1 diabetes specifically would allow for these factors to be assessed routinely in clinical care.
- 20 September 2024
- Published by Wiley in Diabetic Medicine
- Vol. 42 (1) , e15439
Open AccessQualitative study exploring the experiences of sexual dysfunction in premenopausal women with type 1 diabetes
Aims: To explore the sexual experiences and interactions of women with type 1 diabetes to explicate an understanding of the impact of diabetes on women's sexual function. The study was conducted as part of a wider project to develop a patient‐reported outcome measure to assess sexual dysfunction (SD) in premenopausal women with type 1 diabetes.Methods: A qualitative study using face‐to‐face and virtual semi‐structured interviews was conducted with premenopausal women with type 1 diabetes who have had some difficulties related to sexual functioning. Participants were recruited from two National Health Services (NHS) sites in the UK and from social media platforms. The data were analysed to generate themes using Framework Analysis approach.Results: Eighteen women, aged 22–49, were interviewed (NHS sites n = 13; online n = 5). Five themes related to women experiences of SD were identified, these were; initiation of sexual activity, sexual confidence, sexual enjoyment, sexual engagement and sexual desire.Conclusions: SD in women with type 1 diabetes is a complex phenomenon impacting their experiences and quality of life. SD is related to multiple interacting biopsychosocial factors related to diabetes, including blood glucose levels, diabetes treatments, technologies and complications. A targeted measure of SD for women with type 1 diabetes specifically would allow for these factors to be assessed routinely in clinical care.
- 11 October 2023
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 205, 110947
The effects of a couple-based gestational diabetes mellitus intervention on self-management and pregnancy outcomes: A randomised controlled trial
- 11 October 2023
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 205, 110947
The effects of a couple-based gestational diabetes mellitus intervention on self-management and pregnancy outcomes: A randomised controlled trial
- 24 September 2023
- Published by Wiley in Journal of Clinical Nursing
- Vol. 33 (2) , 653-663
A qualitative study exploring partner involvement in the management of gestational diabetes mellitus: The experiences of women and partners
Aims: The aims of the study were to explore the experiences of women with gestational diabetes mellitus (GDM) and their partners and examine the factors influencing partner involvement in GDM management, seeking to inform a targeted couple‐based intervention.Design: A descriptive qualitative study.Methods: We conducted semi‐structured interviews with 14 women with GDM and their partners. Participants were recruited through convenience sampling from a tertiary hospital in Xi'an, China. Data were analysed using thematic analysis.Results: Three themes and 12 subthemes were identified. Theme I: Women's expectations of their partner's involvement in GDM management—practical support and emotional support. Theme II: Partner involvement in GDM management—constructive involvement, unhelpful involvement with good intentions and insufficient involvement. Theme III: Factors that influence partner involvement in GDM—knowledge of GDM, GDM risk perception, health consciousness, attitudes towards the treatment plan, couple communication regarding GDM management, family roles and appraisal of GDM management responsibility.Conclusion: Women desired practical and emotional support from partners. The types of partner involvement in GDM management varied. Some partners provided constructive support, while some partners' involvement was limited, non‐existent or actively unhelpful. By combining these results with the factors influencing partner involvement, our findings may help healthcare professionals develop strategies to involve partners in GDM care and enhance women's ability to manage GDM.Implications for the Profession and Patient Care: Partner involvement in GDM care may help them understand and better attend to women's needs, thus improving their experience and potential outcomes. This study highlights novel factors that need to be considered in developing couple‐based interventions for this population.Reporting Method: The reporting follows the COREQ checklist.Patient or Public Contribution: Some patients were involved in data interpretation. There is no public contribution.
- 24 September 2023
- Published by Wiley in Journal of Clinical Nursing
- Vol. 33 (2) , 653-663
A qualitative study exploring partner involvement in the management of gestational diabetes mellitus: The experiences of women and partners
Aims: The aims of the study were to explore the experiences of women with gestational diabetes mellitus (GDM) and their partners and examine the factors influencing partner involvement in GDM management, seeking to inform a targeted couple‐based intervention.Design: A descriptive qualitative study.Methods: We conducted semi‐structured interviews with 14 women with GDM and their partners. Participants were recruited through convenience sampling from a tertiary hospital in Xi'an, China. Data were analysed using thematic analysis.Results: Three themes and 12 subthemes were identified. Theme I: Women's expectations of their partner's involvement in GDM management—practical support and emotional support. Theme II: Partner involvement in GDM management—constructive involvement, unhelpful involvement with good intentions and insufficient involvement. Theme III: Factors that influence partner involvement in GDM—knowledge of GDM, GDM risk perception, health consciousness, attitudes towards the treatment plan, couple communication regarding GDM management, family roles and appraisal of GDM management responsibility.Conclusion: Women desired practical and emotional support from partners. The types of partner involvement in GDM management varied. Some partners provided constructive support, while some partners' involvement was limited, non‐existent or actively unhelpful. By combining these results with the factors influencing partner involvement, our findings may help healthcare professionals develop strategies to involve partners in GDM care and enhance women's ability to manage GDM.Implications for the Profession and Patient Care: Partner involvement in GDM care may help them understand and better attend to women's needs, thus improving their experience and potential outcomes. This study highlights novel factors that need to be considered in developing couple‐based interventions for this population.Reporting Method: The reporting follows the COREQ checklist.Patient or Public Contribution: Some patients were involved in data interpretation. There is no public contribution.
- Open Access
- 30 December 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (12) , e0273992
The gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial
Objectives: To assess the feasibility of an ante- and post-natal lifestyle intervention for women with gestational diabetes mellitus (GDM) to reduce type 2 diabetes risk.Design: A partially randomised patient preference feasibility trial.Setting: Diabetes antenatal clinics in two inner-London hospitals, UK.Participants: Pregnant women ≥18 years with a GDM diagnosis and pre-pregnancy body mass index of ≥25kg/m2.Intervention: Participants in the intervention group were offered four motivational interview-based sessions (two antenatally and two postnatally, at 3 and 6 months postpartum), a WhatsApp support group, a FitBit and electronic self-help resources.Outcome measures: Recruitment; retention; intervention dose received; data completion; adaptions; proportion achieving ≥5% weight loss; weight change, blood glucose; blood pressure; diet, physical activity, breastfeeding and depression. Clinical outcomes were measured at baseline and 6 months postpartum.Results: 50 participants were recruited from 155 eligible women (32% recruitment rate). Thirty-four were recruited to the intervention group (23 following randomisation (RI-group) and 11 based on preference (PI-group)); and 16 to the control group (13 randomised (RC-group) and 3 preference (PC-group)). Attrition was 44% (n = 22/50). Forty-six percent (n = 6) of the intervention group (25% (n = 2) of the RI-group and 80% (n = 4) of the PI-group) achieved ≥5% weight loss compared to 8% (n = 1) in the control group (95% confidence interval (CI) -0.69 to 0.07). Mean weight change was -2.1kg±9.0 in the intervention group (0kg±5.4 in the RI-group and -5.4kg±13.0 in the PI-group) compared to +4.4kg±4.9 in the control group (RC +4.4kg ±5.3 and PC +4.7kg ±3.1, 95% CI -12.4 to 0.2).Conclusions: Recruitment was feasible, but strategies to improve retention are needed. The findings suggest the intervention can support women with GDM to lose weight. The observed weight loss was primarily in women who preferred the intervention. Therefore, future trials may need to adopt a preference design and consider factors associated with preference.Trial registration: Trial registration:ISRCTN52675820 https://www.isrctn.com/ISRCTN52675820?q=ISRCTN52675820&filters=&sort=&offset=1&totalResults=1&page=1&pageSize=10&searchType=basic-search.
- 30 December 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (12) , e0273992
Open AccessThe gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial
Objectives: To assess the feasibility of an ante- and post-natal lifestyle intervention for women with gestational diabetes mellitus (GDM) to reduce type 2 diabetes risk.Design: A partially randomised patient preference feasibility trial.Setting: Diabetes antenatal clinics in two inner-London hospitals, UK.Participants: Pregnant women ≥18 years with a GDM diagnosis and pre-pregnancy body mass index of ≥25kg/m2.Intervention: Participants in the intervention group were offered four motivational interview-based sessions (two antenatally and two postnatally, at 3 and 6 months postpartum), a WhatsApp support group, a FitBit and electronic self-help resources.Outcome measures: Recruitment; retention; intervention dose received; data completion; adaptions; proportion achieving ≥5% weight loss; weight change, blood glucose; blood pressure; diet, physical activity, breastfeeding and depression. Clinical outcomes were measured at baseline and 6 months postpartum.Results: 50 participants were recruited from 155 eligible women (32% recruitment rate). Thirty-four were recruited to the intervention group (23 following randomisation (RI-group) and 11 based on preference (PI-group)); and 16 to the control group (13 randomised (RC-group) and 3 preference (PC-group)). Attrition was 44% (n = 22/50). Forty-six percent (n = 6) of the intervention group (25% (n = 2) of the RI-group and 80% (n = 4) of the PI-group) achieved ≥5% weight loss compared to 8% (n = 1) in the control group (95% confidence interval (CI) -0.69 to 0.07). Mean weight change was -2.1kg±9.0 in the intervention group (0kg±5.4 in the RI-group and -5.4kg±13.0 in the PI-group) compared to +4.4kg±4.9 in the control group (RC +4.4kg ±5.3 and PC +4.7kg ±3.1, 95% CI -12.4 to 0.2).Conclusions: Recruitment was feasible, but strategies to improve retention are needed. The findings suggest the intervention can support women with GDM to lose weight. The observed weight loss was primarily in women who preferred the intervention. Therefore, future trials may need to adopt a preference design and consider factors associated with preference.Trial registration: Trial registration:ISRCTN52675820 https://www.isrctn.com/ISRCTN52675820?q=ISRCTN52675820&filters=&sort=&offset=1&totalResults=1&page=1&pageSize=10&searchType=basic-search.
- Open Access
- 14 November 2022
- Published by Foundation of European Nurses in Diabetes (FEND) in International Diabetes Nursing
- Vol. 15
A preliminary evaluation of a novel education model for young people with Type 1 diabetes: the Youth Empowerment Skills programme
Background: Adolescence is a challenging time for young people with Type 1 diabetes, associated with worsening glycaemia and disengagement with care. To improve support, we co-designed with young people a novel psychosocially modelled programme of diabetes education (the Youth Empowerment Skills [YES] programme). This study aimed to estimate the clinical impact and feasibility (recruitment, retention and participant experiences) of this programme. Methods: A pilot study using mixed-methods was conducted to assess process and outcomes, involving a pre- and post-exposure assessment of glycaemic control, programme participation data, service utilisation and qualitative semi-structured interviews (analysed using Framework Analysis). Participants were recruited from two hospital diabetes centres in Southeast London. The intervention was conducted in local community centres. Participants were young people with Type 1 diabetes aged 15–21 years. The YES programme involves contact with an outreach youth worker and attending a 3-day psychologically modelled course encompassing social learning, peer facilitation and simulation exercises. The primary outcome was change in HbA1c at 6 and 12-months post-intervention. Secondary outcomes included diabetes-related hospital admissions and incident diabetic ketoacidosis (DKA). Results: Twenty-six young people participated in the programme, mean age 18 (±1.7) years. Uptake was 34% (n = 26) of those approached, with 96% (n = 25) programme completion. Pre-exposure (12 month mean) HbA1c was 93.5 (±29.7) mmol/mol (10.7%), and at 12 months post-exposure, it was 85.1 (±25.4) mmol/mol (10%) (P = 0.01), with 46% (n = 12) of participants achieving a reduction in their HbA1c ≥5.5 mmol/mol (0.5%). Unplanned hospital admissions and DKA rates reduced by 38 and 30%, respectively. The qualitative data identified positive psychosocial impacts including increased diabetes engagement and activation. Active ingredients were social learning, peer support and experiential learning. Participants emphasised the importance of the youth worker in engaging with the programme. Conclusion: The evaluation indicates that the YES programme helps improve young people’s self-confidence in managing diabetes, enhances diabetes engagement and improves clinical outcomes.
- 14 November 2022
- Published by Foundation of European Nurses in Diabetes (FEND) in International Diabetes Nursing
- Vol. 15
Open AccessA preliminary evaluation of a novel education model for young people with Type 1 diabetes: the Youth Empowerment Skills programme
Background: Adolescence is a challenging time for young people with Type 1 diabetes, associated with worsening glycaemia and disengagement with care. To improve support, we co-designed with young people a novel psychosocially modelled programme of diabetes education (the Youth Empowerment Skills [YES] programme). This study aimed to estimate the clinical impact and feasibility (recruitment, retention and participant experiences) of this programme. Methods: A pilot study using mixed-methods was conducted to assess process and outcomes, involving a pre- and post-exposure assessment of glycaemic control, programme participation data, service utilisation and qualitative semi-structured interviews (analysed using Framework Analysis). Participants were recruited from two hospital diabetes centres in Southeast London. The intervention was conducted in local community centres. Participants were young people with Type 1 diabetes aged 15–21 years. The YES programme involves contact with an outreach youth worker and attending a 3-day psychologically modelled course encompassing social learning, peer facilitation and simulation exercises. The primary outcome was change in HbA1c at 6 and 12-months post-intervention. Secondary outcomes included diabetes-related hospital admissions and incident diabetic ketoacidosis (DKA). Results: Twenty-six young people participated in the programme, mean age 18 (±1.7) years. Uptake was 34% (n = 26) of those approached, with 96% (n = 25) programme completion. Pre-exposure (12 month mean) HbA1c was 93.5 (±29.7) mmol/mol (10.7%), and at 12 months post-exposure, it was 85.1 (±25.4) mmol/mol (10%) (P = 0.01), with 46% (n = 12) of participants achieving a reduction in their HbA1c ≥5.5 mmol/mol (0.5%). Unplanned hospital admissions and DKA rates reduced by 38 and 30%, respectively. The qualitative data identified positive psychosocial impacts including increased diabetes engagement and activation. Active ingredients were social learning, peer support and experiential learning. Participants emphasised the importance of the youth worker in engaging with the programme. Conclusion: The evaluation indicates that the YES programme helps improve young people’s self-confidence in managing diabetes, enhances diabetes engagement and improves clinical outcomes.